245 related articles for article (PubMed ID: 34507827)
1. Trends and age-period-cohort effects on mortality of the three major gynecologic cancers in China from 1990 to 2019: Cervical, ovarian and uterine cancer.
Wang Z; Guo E; Yang B; Xiao R; Lu F; You L; Chen G
Gynecol Oncol; 2021 Nov; 163(2):358-363. PubMed ID: 34507827
[TBL] [Abstract][Full Text] [Related]
2. Assessment of secular trends of three major gynecologic cancers burden and attributable risk factors from 1990 to 2019: an age period cohort analysis.
Liu Y; Shi W; Mubarik S; Wang F
BMC Public Health; 2024 May; 24(1):1349. PubMed ID: 38764017
[TBL] [Abstract][Full Text] [Related]
3. Incidence and mortality of gynaecological cancers: Secular trends in urban Shanghai, China over 40 years.
Huang Z; Zheng Y; Wen W; Wu C; Bao P; Wang C; Zhong W; Gao YT; Jin F; Xiang YB; Shu XO; Beeghly-Fadiel A
Eur J Cancer; 2016 Aug; 63():1-10. PubMed ID: 27254837
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the disease burden trend of malignant tumors of the female reproductive system in China from 2006 to 2020.
Han X; Wang Z; Huang D; Deng K; Wang Q; Li C; Zhu J
BMC Womens Health; 2022 Dec; 22(1):504. PubMed ID: 36476597
[TBL] [Abstract][Full Text] [Related]
5. [Common Malignant Tumors in the Reproductive System of Chinese Women: Disease Burden During 1990-2019 and Prediction of Future Trend].
Zheng N; Tang J; Ren XM
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2024 Feb; 46(1):25-32. PubMed ID: 38433627
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathologic features, incidence, and survival trends of gynecologic neuroendocrine tumors: a SEER database analysis.
Gibbs J; Mei S; Economos K; Lee YC; Kanis MJ
Am J Obstet Gynecol; 2019 Jul; 221(1):53.e1-53.e6. PubMed ID: 30849352
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Secular Trends in Cervical Cancer Mortality in China and the United States: An Age-Period-Cohort Analysis.
Wang J; Bai Z; Wang Z; Yu C
Int J Environ Res Public Health; 2016 Nov; 13(11):. PubMed ID: 27869688
[No Abstract] [Full Text] [Related]
8. The mortalities of female-specific cancers in China and other countries with distinct socioeconomic statuses: A longitudinal study.
Jiang D; Niu Z; Tan X; He H; Ren L; Shen J; Zhu X; Zhao P; Liu M; Chen H; Wang R; Li Q; Cao G
J Adv Res; 2023 Jul; 49():127-139. PubMed ID: 36130684
[TBL] [Abstract][Full Text] [Related]
9. Temporal Trends of Common Female Malignances on Breast, Cervical, and Ovarian Cancer Mortality in Japan, Republic of Korea, and Singapore: Application of the Age-Period-Cohort Model.
Wang J; Lv H; Xue Z; Wang L; Bai Z
Biomed Res Int; 2018; 2018():5307459. PubMed ID: 29750160
[TBL] [Abstract][Full Text] [Related]
10. Trends in gynecologic cancer mortality in East Asian regions.
Lee JY; Kim EY; Jung KW; Shin A; Chan KK; Aoki D; Kim JW; Low JJ; Won YJ
J Gynecol Oncol; 2014 Jul; 25(3):174-82. PubMed ID: 25045429
[TBL] [Abstract][Full Text] [Related]
11. Mortality trends and disease burdens of cervical, endometrial and ovarian cancers from 1981 to 2020 in Taiwan.
Su SY
Prev Med; 2023 Jul; 172():107551. PubMed ID: 37211252
[TBL] [Abstract][Full Text] [Related]
12. Mortality rates due to gynecologic cancers in New York state by demographic factors and proximity to a Gynecologic Oncology Group member treatment center: 1979-2001.
Tan W; Stehman FB; Carter RL
Gynecol Oncol; 2009 Aug; 114(2):346-52. PubMed ID: 19411096
[TBL] [Abstract][Full Text] [Related]
13. Cervical, uterine corpus, and ovarian cancer mortality in Greece during 1980 to 2005: a trend analysis.
Pavlidou E; Zafrakas M; Papadakis N; Benos A; Agorastos T
Int J Gynecol Cancer; 2010 May; 20(4):482-7. PubMed ID: 20686368
[TBL] [Abstract][Full Text] [Related]
14. Women's cancers in China: a spatio-temporal epidemiology analysis.
He R; Zhu B; Liu J; Zhang N; Zhang WH; Mao Y
BMC Womens Health; 2021 Mar; 21(1):116. PubMed ID: 33743648
[TBL] [Abstract][Full Text] [Related]
15. Ovarian, uterine, and cervical cancer patients with distant metastases at diagnosis: most common locations and outcomes.
Gardner AB; Charo LM; Mann AK; Kapp DS; Eskander RN; Chan JK
Clin Exp Metastasis; 2020 Feb; 37(1):107-113. PubMed ID: 31758289
[TBL] [Abstract][Full Text] [Related]
16. Mortality predictions for Ireland, 2001-2015: cancers of the breast, ovary, and cervix and Corpus uteri.
O'Lorcain P; Comber H
Int J Gynecol Cancer; 2006; 16 Suppl 1():1-10. PubMed ID: 16515560
[TBL] [Abstract][Full Text] [Related]
17. Historical trends in breast Cancer among women in China from age-period-cohort modeling of the 1990-2015 breast Cancer mortality data.
Ding Y; Chen X; Zhang Q; Liu Q
BMC Public Health; 2020 Aug; 20(1):1280. PubMed ID: 32843006
[TBL] [Abstract][Full Text] [Related]
18. [History of cancer therapy].
Yamabe T
Nihon Rinsho; 2004 Oct; 62 Suppl 10():22-7. PubMed ID: 15535200
[No Abstract] [Full Text] [Related]
19. Age-period-cohort analyses of breast-, ovarian-, endometrial- and cervical-cancer mortality rates for Caucasian women in the USA.
Tarone RE; Chu KC
J Epidemiol Biostat; 2000; 5(4):221-31. PubMed ID: 11055272
[TBL] [Abstract][Full Text] [Related]
20. Grand multiparity and reproductive cancer in the Jerusalem Perinatal Study Cohort.
Paltiel O; Tajuddin SM; Polanker Y; Yazdgerdi S; Manor O; Friedlander Y; Harlap S; Calderon-Margalit R
Cancer Causes Control; 2016 Feb; 27(2):237-47. PubMed ID: 26669321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
